Finance

Lists
LSL:CVE
LSL Pharma Group Inc
CA$0.33
0.00%
(0.00) 1D
Sep 4, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for LSL...
Open
CA$0.32
High
CA$0.34
Low
CA$0.32
Mkt. cap
41.82M
Avg. vol.
44.18K
Volume
36.50K
52-wk high
CA$0.56
52-wk low
CA$0.30
EPS
-CA$0.06
Beta
-0.24
Shares outstanding
126.73M
No. of employees
252
Open
CA$0.32
High
CA$0.34
Low
CA$0.32
Mkt. cap
41.82M
Avg. vol.
44.18K
Volume
36.50K
52-wk high
CA$0.56
52-wk low
CA$0.30
EPS
-CA$0.06
Beta
-0.24
Shares outstanding
126.73M
No. of employees
252
About LSL Pharma Group Inc
CEO-
Employees252
Founded2010
Headquarters-
SectorPersonal care products
Websitegroupelslpharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.58M
7.32M
12.30M
14.63M
Cost of goods sold
5.24M
7.00M
11.53M
12.88M
Cost of revenue
5.24M
7.00M
11.53M
12.88M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.71M
2.41M
2.51M
2.36M
Operating expense
1.94M
2.05M
2.60M
2.85M
Total operating expenses
7.18M
9.05M
14.14M
15.73M
Operating income
394.00K
-1.72M
-1.84M
-1.10M
Other non operating income
-59.00K
-63.00K
-74.00K
-42.00K
EBT including unusual items
-1.18M
-1.16M
-2.82M
-2.24M
EBT excluding unusual items
-423.00K
-2.54M
-2.82M
-2.24M
Income tax expense
-
-65.00K
-
-
Effective tax rate
-
5.60%
-
-
Other operating expenses
-
-
-
-
Net income
-1.18M
-1.10M
-2.82M
-2.24M
Net profit margin
-15.58%
-14.96%
-22.90%
-15.33%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-758.00K
-752.00K
-908.00K
-1.10M
Net interest expenses
-758.00K
-752.00K
-908.00K
-1.10M
Depreciation and amortization charges
142.00K
-407.00K
84.00K
439.00K
EBITDA
1.00M
-1.57M
-1.02M
-27.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps